LLY
Eli Lilly and Company · DUS:LLY
1,248.80 EUR−10.60 −0.84%
Eli Lilly and Company (DUS:LLY) last traded at 1,248.80 EUR, down 0.84% on the day. Over the past year the stock is up 66.84%. Its 52-week range is 728.40 to 1,280.40. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open1,247.80
Day range1,247.80 – 1,251.60
52-week range728.40 – 1,280.40
Volume0
Average volume (10 days)2
Market cap (USD)1.33 T
P/E46.48
EPS (TTM) (USD)30.44
Dividend yield0.47%
Beta (1 year)0.3795
Revenue (TTM) (USD)86.46 B
Employees50.00 K
Performance
+9.01%1 week
+22.31%1 month
+27.64%3 months
+48.83%6 months
+36.02%Year to date
+66.84%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- How to Invest in the Rise of China's Biotech: Buy U.S. Drug Stocks — Barrons.comDow Jones Newswires · 03 Nov 2026
- LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold?Zacks · 03 Nov 2026
- Eli Lilly Stocks Move Lower With Higher Target Facing a Volume-Price TradeoffGuruFocus · 02 Nov 2026
- Eli Lilly Is Maintained at Overweight by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
- Cathie Wood's weekly recap: loads TER, AVAV after strong results; books gain in AMD, TSM, LLYSeeking Alpha · 02 Nov 2026
- Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
- Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.